Physician profile
Eric S Powitzky
NPI 1952383200
$10,453.80
in general payments reported to CMS, 2019-2025
20 companies · $1,290 in 2025
The $1,290 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $224 · 2021: $344 · 2022: $968 · 2023: $6,783 · 2024: $432 · 2025: $1,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $3,089 · Travel and Lodging: $1,316 · Education: $99.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $3,089.41 |
| Travel and Lodging | $1,316.25 |
| Education | $99.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,901.67 | 2022-2024 | Propel, Cd Horizon Spinal System, Nuvent |
| Inspire Medical Systems, INC. | $1,755.19 | 2022-2025 | Inspire |
| Optinose US, INC. | $779.12 | 2019-2025 | |
| Aerin Medical INC. | $535.83 | 2020-2025 | |
| Intersect Ent, INC. | $220.28 | 2019-2021 | |
| Genzyme Corporation | $201.32 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $199.50 | 2022-2025 | Dupixent |
| Stryker Corporation | $197.45 | 2019-2021 | |
| Acclarent, INC | $154.83 | 2019-2021 | |
| Ars Pharmaceuticals Operations, INC. | $141.09 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $139.18 | 2023-2025 | Nucala |
| Kaleo, INC. | $98.53 | 2020-2023 | Auvi-Q |
| Integra Lifesciences Corporation | $22.22 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $20.68 | 2025 | Tezspire |
| Medical Device Business Services, INC. | $18.09 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.62 | 2025 | Zepbound |
| Olympus America INC. | $15.39 | 2023 | Olympus |
| Hikma Pharmaceuticals USA | $13.88 | 2024 | Ryaltris |
| Novartis Pharmaceuticals Corporation | $13.33 | 2019 | |
| Checkpoint Surgical, INC | $9.60 | 2025 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Powitzky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.